These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29952659)

  • 21. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymyositis/dermatomyositis--clinical picture and treatment].
    Anić B; Cerovec M
    Reumatizam; 2012; 59(2):44-50. PubMed ID: 23745455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Semin Neurol; 2012 Jul; 32(3):227-36. PubMed ID: 23117947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroids in Myositis and Scleroderma.
    Postolova A; Chen JK; Chung L
    Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory myopathies].
    Cherin P
    Rev Prat; 2001 Feb; 51(3):270-7. PubMed ID: 11265423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies.
    de Souza FHC; de Araújo DB; Vilela VS; Bezerra MC; Simões RS; Bernardo WM; Miossi R; da Cunha BM; Shinjo SK
    Adv Rheumatol; 2019 Jan; 59(1):6. PubMed ID: 30670084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E; Tansley SL; McHugh NJ
    Clin Rheumatol; 2015 Dec; 34(12):2089-95. PubMed ID: 26299472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of dermatomyositis and polymyositis.
    Choy EH; Isenberg DA
    Rheumatology (Oxford); 2002 Jan; 41(1):7-13. PubMed ID: 11792873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].
    Genth E
    Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent clinical trials in idiopathic inflammatory myopathies.
    Leclair V; Lundberg IE
    Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
    Oddis CV; Reed AM; Aggarwal R; Rider LG; Ascherman DP; Levesque MC; Barohn RJ; Feldman BM; Harris-Love MO; Koontz DC; Fertig N; Kelley SS; Pryber SL; Miller FW; Rockette HE;
    Arthritis Rheum; 2013 Feb; 65(2):314-24. PubMed ID: 23124935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
    Göttfried I; Seeber A; Anegg B; Pirkhammer D; Rieger A; Stingl G; Volc-Platzer B
    Wien Klin Wochenschr; 1996 Nov; 108(22):705-16. PubMed ID: 9157716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P; Herson S
    Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic inflammatory myopathies.
    van der Kooi AJ; de Visser M
    Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.